Skip to main content

Animations

MJFF Publications

1301 - 1310 of 6431 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2023.1269387
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson Disease
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000200115
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Comparative analysis of methods to reduce activation signature gene expression in PBMCs
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-49611-2
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1002/mds.29611
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad346
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad331
    Citation Count: 16
  • Summary Details
    OPEN
    Title: PTPA variants and the risk for Parkinson’s disease in diverse ancestry populations
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awad247
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The non-specific lethal complex regulates genes and pathways genetically linked to Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awad246
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00738-4
    Citation Count: 8
  • Summary Details
    OPEN
    Title: A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1557
    Citation Count: 53
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.